Clinical Endocannabinoid Deficiency is a term regularly used in the medical cannabis world and refers to a collection of illnesses where low levels of endocannabinoids and their receptors contribute to disease development.
So who better to speak to for a deep dive into endocannabinoid deficiency than Dr Ethan Russo, the neurologist and cannabinoid researcher who coined the term and has written three papers on the subject.
Ethan shares how he initially came up with the theory, possible causes, which conditions share the cluster of symptoms associated with endocannabinoid deficiency, we discuss how poor endocannabinoid tone may contribute to the development of endometriosis, and how best we can strengthen our endocannabinoid system supplementing with cannabis, but also through non-cannabis routes such as looking after our gut biome and exercise.
This episode is a must for doctors, patients and indeed anyone with an interest in deepening their understanding of the endocannabinoid system and how its dysregulation may well lie behind a host of pathologies.
Clinical endocannabinoid deficiency (CECD): can this concept explain therapeutic benefits of cannabis in migraine, fibromyalgia, irritable bowel syndrome and other treatment-resistant conditions? by Ethan Russo
Clinical Endocannabinoid Deficiency Reconsidered: Current Research Supports the Theory in Migraine, Fibromyalgia, Irritable Bowel, and Other Treatment-Resistant Syndromes by Ethan Russo
Support the show